Details of the Drug Formulation (DFM)
| General Information of DFM (ID: F20295) | |||||
|---|---|---|---|---|---|
| Name |
Sodium fluoride 0.55 mg tablet
|
||||
| Company |
PureTek Corporation
|
||||
| Active Pharmaceutical Ingredient (API) | Sodium fluoride |
API Info
click to show the detail info of this API
|
|||
| Periodontal disease | ICD-11: DA0C | Approved | |||
| Drug Inactive Ingredient (DIGs) | |||||
| DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
| E03SQI | DIG Info | Carmellose sodium | Disintegrant | ||
| E06RUT | DIG Info | D&C red no. 27 | Colorant | ||
| E01UTP | DIG Info | Magnesium stearate | lubricant | ||
| E0Q6DQ | DIG Info | Mannitol | Diluent ... | ||
| E0Q3PU | DIG Info | Saccharose | Binding agent ... | ||
| Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
|---|---|---|---|---|---|---|
| Oxidoreductase (ORase) | ||||||
| DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Magnesium stearate | |||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carmellose sodium | |||||
| Biological Activity | Protein expression upregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (3) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carmellose sodium | |||||
| Biological Activity | Protein expression upregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Transferase (TFase) | ||||||
| DBT Name: Arginine methyltransferase 1 (PRMT1) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | D&C red no. 27 | |||||
| Biological Activity | IC50 = 1400 nM (estimated based on the structural similarity with CHEMBL376503 ) | [2] | ||||
| Structural Similarity | Tanimoto coefficient = 0.781914894 | |||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | ANM1_HUMAN | |||||
| Potential-driven transporter (PDT) | ||||||
| DBT Name: Solute carrier SLCO2B1 (OATPB) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | D&C red no. 27 | |||||
| Biological Activity | Inhibition ratio = 69 % (tested by experiment) | [3] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | SO2B1_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | D&C red no. 27 | |||||
| Biological Activity | Ki = 1 uM (tested by experiment) | [3] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | SO2B1_HUMAN | |||||
| Transmembrane channel/porin (TC/P) | ||||||
| DBT Name: Glycine receptor alpha-1 (GLRA1) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Mannitol | |||||
| Biological Activity | EC50 = 12589.25 nM (estimated based on the structural similarity with CHEMBL604608 ) | [4] | ||||
| Structural Similarity | Tanimoto coefficient = 0.804878049 | |||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | GLRA1_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

